These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 21648420)

  • 1. Comparison of lysophospholipid levels in rat feces with those in a standard chow.
    Inoue M; Adachi M; Shimizu Y; Tsutsumi T; Tokumura A
    J Agric Food Chem; 2011 Jul; 59(13):7062-7. PubMed ID: 21648420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addition of high load of lysophosphatidic acid to standard and high-fat chows causes no significant changes of its circulating and peripheral tissue levels but affects body weight and visceral fat mass of mice.
    Inoue M; Okamoto Y; Atsumi Y; Shiojiri M; Hidaka M; Tanaka T; Tsutsumi T; Shirasaka N; Tokumura A
    Biofactors; 2018 Nov; 44(6):548-557. PubMed ID: 30368958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of lysophosphatidic acids in rat brain tissue by liquid chromatography-electrospray tandem mass spectrometry.
    Aaltonen N; Laitinen JT; Lehtonen M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(15-16):1145-52. PubMed ID: 20381434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging lysophospholipid mediators, lysophosphatidylserine, lysophosphatidylthreonine, lysophosphatidylethanolamine and lysophosphatidylglycerol.
    Makide K; Kitamura H; Sato Y; Okutani M; Aoki J
    Prostaglandins Other Lipid Mediat; 2009 Sep; 89(3-4):135-9. PubMed ID: 19427394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrospray ionization mass spectrometry analysis of lysophospholipids in human ascitic fluids: comparison of the lysophospholipid contents in malignant vs nonmalignant ascitic fluids.
    Xiao YJ; Schwartz B; Washington M; Kennedy A; Webster K; Belinson J; Xu Y
    Anal Biochem; 2001 Mar; 290(2):302-13. PubMed ID: 11237333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered plasma levels of lysophospholipids in response to adrenalectomy of rats.
    Tsutsumi T; Ino M; Shimizu Y; Kawabata K; Nishi H; Tokumura A
    Prostaglandins Other Lipid Mediat; 2021 Oct; 156():106579. PubMed ID: 34245896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of new phase II metabolites of xanthohumol in rat in vivo biotransformation of hop extracts using high-performance liquid chromatography electrospray ionization tandem mass spectrometry.
    Jirásko R; Holcapek M; Vrublová E; Ulrichová J; Simánek V
    J Chromatogr A; 2010 Jun; 1217(25):4100-8. PubMed ID: 20227705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous separation of lysophospholipids from the total lipid fraction of crude biological samples using two-dimensional thin-layer chromatography.
    Yokoyama K; Shimizu F; Setaka M
    J Lipid Res; 2000 Jan; 41(1):142-7. PubMed ID: 10627512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct quantitative analysis of lysophosphatidic acid molecular species by stable isotope dilution electrospray ionization liquid chromatography-mass spectrometry.
    Baker DL; Desiderio DM; Miller DD; Tolley B; Tigyi GJ
    Anal Biochem; 2001 May; 292(2):287-95. PubMed ID: 11355863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid chromatography mass spectrometry for quantifying plasma lysophospholipids: potential biomarkers for cancer diagnosis.
    Murph M; Tanaka T; Pang J; Felix E; Liu S; Trost R; Godwin AK; Newman R; Mills G
    Methods Enzymol; 2007; 433():1-25. PubMed ID: 17954226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of diet-induced obesity by dietary isomerized hop extract containing isohumulones, in rodents.
    Yajima H; Noguchi T; Ikeshima E; Shiraki M; Kanaya T; Tsuboyama-Kasaoka N; Ezaki O; Oikawa S; Kondo K
    Int J Obes (Lond); 2005 Aug; 29(8):991-7. PubMed ID: 15852044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of central leptin sensitivity and energy balance in a rat model of diet-induced obesity.
    Fam BC; Morris MJ; Hansen MJ; Kebede M; Andrikopoulos S; Proietto J; Thorburn AW
    Diabetes Obes Metab; 2007 Nov; 9(6):840-52. PubMed ID: 17924866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced kidney levels of lysophosphatidic acids in rats after chronic administration of aristolochic acid: Its possible protective role in renal fibrosis.
    Tsutsumi T; Yamakawa S; Ishihara A; Yamamoto A; Tanaka T; Tokumura A
    Toxicol Rep; 2015; 2():121-129. PubMed ID: 28962344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dietary fibre mixture on growth and intestinal iron absorption in rats recovering from iron-deficiency anaemia.
    Weber TK; Freitas Kde C; Amancio OM; de Morais MB
    Br J Nutr; 2010 Nov; 104(10):1471-6. PubMed ID: 20687971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural differences in the ability of lysophospholipids to inhibit endothelium-dependent hyperpolarization by acetylcholine in rat mesenteric arteries.
    Fukao M; Hattori Y; Kanno M; Sakuma I; Kitabatake A
    Biochem Biophys Res Commun; 1996 Oct; 227(2):479-83. PubMed ID: 8878540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of circulatory and excretory metabolites of meisoindigo in rat plasma, urine and feces by high-performance liquid chromatography coupled with positive electrospray ionization tandem mass spectrometry.
    Huang M; Lee YS; Ho PC
    Rapid Commun Mass Spectrom; 2010 Mar; 24(6):729-41. PubMed ID: 20169560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the bioavailability and metabolism in the rat of punicalagin, an antioxidant polyphenol from pomegranate juice.
    Cerdá B; Llorach R; Cerón JJ; Espín JC; Tomás-Barberán FA
    Eur J Nutr; 2003 Jan; 42(1):18-28. PubMed ID: 12594538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The component changes of lysophospholipid mediators in colorectal cancer.
    Kitamura C; Sonoda H; Nozawa H; Kano K; Emoto S; Murono K; Kaneko M; Hiyoshi M; Sasaki K; Nishikawa T; Shuno Y; Tanaka T; Hata K; Kawai K; Aoki J; Ishihara S
    Tumour Biol; 2019 May; 41(5):1010428319848616. PubMed ID: 31106679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Separation and quantitation of phospholipids and lysophospholipids by high-performance liquid chromatography.
    Lesnefsky EJ; Stoll MS; Minkler PE; Hoppel CL
    Anal Biochem; 2000 Oct; 285(2):246-54. PubMed ID: 11017709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.